Pfizer works to lower manufacturing costs

"Profitability comes from low-cost manufacturing," says Jean-Michel Halfon, Pfizer president for emerging markets. "Low-cost solutions developed in emerging markets could be useful everywhere. We're working on it." Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.